Moreover, silencing of the CK2α subunit leads to MKK4 activation and, consequently, significant death of PANC-1 human pancreatic cancer cells treated with gemcitabine60, which displays methuosis-like traits. Here, MAP2K4 is linked to pancreatic neoplasm.